Literature DB >> 8749706

Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

M Saresella1, A Grope, L Speciale, R Mancuso, R De Benedictis, D Caputo, P Ferrante.   

Abstract

Peripheral blood (PB) and cerebrospinal fluid (CSF) lymphocyte subpopulations, defined by various T-cell specific monoclonal antibodies and flow cytometry, were analysed in 44 relapsing remitting multiple sclerosis (RRMS) patients (including 21 subjects in the acute phase and 23 in the stable phase), 40 chronic-progressive multiple sclerosis (CPMS) patients, and 24 patients with other neurological diseases (OND), in order to verify the presence of any abnormality in the lymphocyte subset pattern. A significant increase in the total number of T-lymphocytes and the CD4+ subpopulation was found in the PB of the MS patients in comparison with the OND group. Moreover, a not statistically significant increase in CD4+ cells was observed in the CSF of MS patients. A statistically significant increase was also found in the CD4+ Leu 8+ (suppressor inducer) cells in the CSF of all of the MS groups. Finally, the CD8+ (suppressor/cytotoxic) cell levels, were significantly lower in the CSF of CPMS and stable RMS patients than in the CSF of the OND patients. As a whole, our data suggest that the immunosuppressive deficit that seems to be a constant finding in MS is not due to a decrease in suppressor inducer cell levels, as previously suggested, but may be caused by a missed or altered signal from the suppressor inducer to CD8+ suppressor cells.

Entities:  

Mesh:

Year:  1995        PMID: 8749706     DOI: 10.1007/bf02229326

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  26 in total

1.  Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.

Authors:  M Chofflon; H L Weiner; C Morimoto; D A Hafler
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

2.  The cellular basis for the induction of antigen-specific T8 suppressor cells.

Authors:  C Morimoto; N L Letvin; J A Distaso; H M Brown; S F Schlossman
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

3.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  Comparison of T8+ cell-mediated suppressor and cytotoxic functions in multiple sclerosis.

Authors:  J P Antel; M K Nicholas; M B Bania; A T Reder; B G Arnason; L Joseph
Journal:  J Neuroimmunol       Date:  1986-09       Impact factor: 3.478

5.  Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.

Authors:  M Chofflon; H L Weiner; C Morimoto; D A Hafler
Journal:  Ann Neurol       Date:  1988-08       Impact factor: 10.422

Review 6.  MS: a CNS and systemic autoimmune disease.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Today       Date:  1989-03

7.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Suppressor cell function in multiple sclerosis: correlation with clinical disease activity.

Authors:  J P Antel; B G Arnason; M E Medof
Journal:  Ann Neurol       Date:  1979-04       Impact factor: 10.422

9.  T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients.

Authors:  R Scolozzi; A Boccafogli; M R Tola; L Vicentini; A Camerani; D Degani; E Granieri; L Caniatti; E Paolino
Journal:  J Neurol Sci       Date:  1992-03       Impact factor: 3.181

10.  Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.

Authors:  M Matsui; K J Mori; T Saida
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.